- Category
- Micro (2022-23)
- Udyam number
- UDYAM-HP-11-0013393

Axolab Formulations Private Limited
About Axolab Formulations Private Limited
Data last updated:
Axolab Formulations Private Limited is a private limited company based in Solan, Himachal Pradesh, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 28 September 2022.
The company is registered with the Registrar of Companies (ROC), Himachal Pradesh, under CIN U24230HP2022PTC009591.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors including Sarthak Goyal and Nishant Mehta.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Khasra No 699/2 & 700/4 Mauja, Village Kishanpura Tehsil Baddi Kishanpura Solan Hp, Himachal Pradesh, India – 174101.
As per the financials filed for FY 2025, the company reported a revenue of ₹5.29 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹27.97 Lakh (net margin -5.3%) and EBITDA of ₹5.72 Lakh (EBITDA margin 1.1%).
As per MCA filings, the company has open charges of ₹1 Cr on record.
Axolab Formulations Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-HP-11-0013393). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Recognitions & Rankings of Axolab Formulations
Contact details
Axolab Formulations Private Limited's registered office is in Solan, Himachal Pradesh.
- Registered AddressKhasra No 699/2 & 700/4 Mauja, Village Kishanpura Tehsil Baddi Kishanpura Solan Hp, Himachal Pradesh, India – 174101
- IndustryChemicals, Manufacturing, Other Chemical Product
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Axolab Formulations is manufacturing. In detail, this covers manufacture of chemicals and chemical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | 20 | Manufacture of chemicals and chemical products |
To see the full business activity and turnover split of Axolab Formulations Private Limited, buy the company report.
Financials of Axolab Formulations Private Limited
FY 2025 filings availableAxolab Formulations Private Limited reported revenue of ₹5.29 Cr (up 824% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 824% in the latest year. EBITDA rose 146% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | ₹5.72 Lakh | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | -₹27.97 Lakh | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | 1.1% | ||
| Net Profit Margin | -5.3% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Axolab Formulations Private Limited, buy the company report.
Board of directors of Axolab Formulations Private Limited
Axolab Formulations has 4 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sarthak Goyal Also directs: Anvish Healthcare LLP, Frentis Healthcare Private Limited | Director | 28 Sep 2022 | 4 Years 1 Months | Current |
| Nishant Mehta | Director | 16 Aug 2023 | 3 Years 2 Months | Current |
| Navneet Singh Thakur Also directs: Capiq Pharmaceuticals Private Limited | Director | 28 Sep 2022 | 4 Years 1 Months | Current |
| Munish Goyal Also directs: Capiq Pharmaceuticals Private Limited | Director | 28 Sep 2022 | 4 Years 1 Months | Current |
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 20 Mar 2025 | 101077414 | State Bank of India | ₹1 Cr | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Axolab Formulations Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Axolab Formulations Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Axolab Formulations Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Axolab Formulations Private Limited has 6 board changes on record since 2022: 4 appointments and 2 cessations. The latest: Nishant Mehta ceased to be Additional Director on 30 Dec 2023.
Frequently asked questions
Axolab Formulations is an active private limited company based in Solan, Himachal Pradesh, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 28 September 2022 (4+ years old) and is registered under CIN U24230HP2022PTC009591.
Axolab Formulations has 4 current directors:
- Sarthak Goyal - Director
- Nishant Mehta - Director
- Navneet Singh Thakur - Director
- Munish Goyal - Director
The latest financial statements of Axolab Formulations on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2023 are in the company report.
The CIN (Corporate Identification Number) of Axolab Formulations is U24230HP2022PTC009591. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Axolab Formulations was incorporated on 28 September 2022, making it 4+ years old. It is registered with the Registrar of Companies, Himachal Pradesh.
Nishant Mehta ceased to be Additional Director on 30 Dec 2023. Akash Deep ceased to be Director on 16 Aug 2023. Nishant Mehta was appointed as Director on 16 Aug 2023. Axolab Formulations has 6 board changes on record in total.
Yes, Axolab Formulations is registered as a micro enterprise under Udyam registration (number: UDYAM-HP-11-0013393).
The registered office of Axolab Formulations is at Khasra No 6992 & 7004 Mauja, Village Kishanpura Tehsil Baddi Kishanpura Solan Hp, Himachal Pradesh, India – 174101.
Axolab Formulations operates in the chemicals industry, in the manufacturing segment.
Axolab Formulations has open charges of ₹1 Cr and no satisfied charges on record as per latest MCA filings.

